





The Open Access Institutional Repository 




This is an author produced version of a paper published in  
 
Acta Biochimica Polonica (ISSN 0001-527X) 
 
This version may not include final proof corrections and does not include 





Citation for the version of the work held in ‘OpenAIR@RGU’: 
 
DEVER, G., WAINWRIGHT, C. L., KENNEDY, S. and SPICKETT, C. M., 
2006. Fatty acid and phospholipid chlorohydrins cause cell stress 
and endothelial adhesion. Available from OpenAIR@RGU. [online]. 
Available from: http://openair.rgu.ac.uk 
 
 
Citation for the publisher’s version: 
 
DEVER, G., WAINWRIGHT, C. L., KENNEDY, S. and SPICKETT, C. M., 
2006. Fatty acid and phospholipid chlorohydrins cause cell stress 





Items in ‘OpenAIR@RGU’, Robert Gordon University Open Access Institutional Repository, 
are protected by copyright and intellectual property law. If you believe that any material 
held in ‘OpenAIR@RGU’ infringes copyright, please contact openair-help@rgu.ac.uk with 
details. The item will be removed from the repository while the claim is investigated. 
Regular paper
Fatty acid and phospholipid chlorohydrins cause cell stress 
and endothelial adhesion*
Gary Dever, Cherry L. Wainwright1, Simon Kennedy2 and Corinne M. Spickett*
Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK;  
*e-mail: c.m.spickett@strath.ac.uk
Received: 17 October, 2006; revised: 13 November, 2006; accepted: 16 November, 2006 
available on-line: 27 November, 2006
The oxidation of low-density lipoprotein (LDL) is thought to contribute to atherogenesis, which 
is an inflammatory disease involving activation of phagocytic cells. Myeloperoxidase, an enzyme 
which is able to produce hypochlorous acid (HOCl), is released from these phagocytic cells, and 
has been found in an active form in atherosclerotic plaques. HOCl can oxidize both the lipid 
and protein moiety of LDL, and HOCl-modified LDL has been found to be pro-inflammatory, 
although it is not known which component is responsible for this effect. As HOCl can oxidize 
lipids to give chlorohydrins, we hypothesized that phospholipid chlorohydrins might have tox-
ic and pro-inflammatory effects. We have formed chlorohydrins from fatty acids (oleic, linoleic 
and arachidonic acids) and from phospholipids (stearoyl-oleoyl phosphatidylcholine, stearoyl-li-
noleoyl phosphatidylcholine and stearoyl-arachidonoyl phosphatidylcholine), and investigated 
various biological effects of these oxidation products. Fatty acid and phospholipid chlorohydrins 
were found to deplete ATP levels in U937 cells in a concentration-dependent manner, with sig-
nificant effects observed at concentrations of 25 µM and above. Low concentrations (25 µM) of 
stearoyl-oleoyl phosphatidylcholine and stearoyl-arachidonoyl phosphatidylcholine chlorohydrins 
were also found to increase caspase-3 activity. Finally, stearoyl-oleoyl phosphatidylcholine chlo-
rohydrin increased leukocyte adhesion to artery segments isolated from C57Bl/6 mice. These re-
sults demonstrate potentially harmful effects of lipid chlorohydrins, and suggest that they may 
contribute to some of the pro-inflammatory effects that HOCl-modified low density lipoprotein 
has been found to induce. 
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InTrODUCTIOn
Atherosclerosis is now considered as an in-
flammatory condition, involving immune cell ac-
tivation and infiltration into the intima, together 
with increased infiltration of low density lipoprotein 
(Ross, 1993; Madamanchi et al., 2005). It is also well 
established that the oxidation of low density lipo-
protein (LDL) is a key risk factor for atherosclerosis 
(Witztum & Steinberg, 1991), and that oxidized LDL 
(oxLDL) can contribute to the disease pathology via 
several different mechanisms. One way that LDL 
can be oxidized is by the action of the phagocyte 
enzyme myeloperoxidase, which produces HOCl, 
among other oxidants. There is now very strong 
evidence for the involvement of myeloperoxidase 
in atherosclerosis (Podrez et al., 2000; Brennan & 
Hazen, 2003). Early research showed that myeloper-
oxidase is present in an active form in atherosclerot-
ic lesions (Daugherty et al., 1994), and HOCl-modi-
fied epitopes of LDL were detected in lesions using 
a specific monoclonal antibody (Hazell & Heinecke, 
1997). It was also found that chlorotyrosine deriva-
tives, which are considered to be markers of mye-
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loperoxidase activity, have been detected at various 
stages of lesion development and are elevated in 
LDL and HDL isolated from atherosclerotic lesions 
(Hazen & Heinecke, 1997; Bergt et al., 2004). Chlorin-
ated lipids, in the form of α-chloro fatty aldehydes, 
have also been detected in atherosclerotic plaque 
samples (Thukkani et al., 2003). As well as products 
of myeloperoxidase and HOCl attack, the free HOCl 
concentration may reach high concentrations in in-
flammatory sites, with one study estimating concen-
trations in the region of 300 µM (Katrantzis et al., 
1991).
HOCl is an oxidizing and chlorinating com-
pound that is able to attack many biological mole-
cules. When incubated with low density lipoprotein, 
it causes both protein oxidation, of which lysine and 
cysteine residues react particularly readily, and lipid 
oxidation and peroxidation (Hazell et al., 1997; Carr 
et al., 2000). The main reaction of HOCl with unsatu-
rated fatty acyl chains is the formation of chloro-
hydrins (Winterbourn et al., 1992), and it is known 
that treatment of isolated human LDL with either 
HOCl or myeloperoxidase, at concentrations similar 
to those thought to occur in atherosclerotic lesions, 
results in generation of phospholipid chlorohydrins 
(Jerlich et al., 2000). It has been found that HOCl-
oxidized LDL has some pro-inflammatory effects, 
such as induction of the chemotactic cytokine IL-8 
in human monocytes and stimulation of neutrophil 
chemotaxis (Woenckhaus et al., 1998), activation of 
the NADPH oxidase in macrophages derived from 
THP-1 and U937 cells (Nguyen-Khoa et al., 1999), 
and enhanced adhesion of polymorphonuclear leu-
kocytes to human umbilical vein endothelial cells 
(Kopprasch et al., 1998). For some effects of HOCl-
modified LDL, it has been suggested that they are 
mediated via oxidation of the protein moiety (Nguy-
en-Khoa et al., 1999), but there is still considerable 
doubt for other effects, and overall the precise modi-
fications and mechanisms responsible have not been 
identified.
As it is known that free radical oxidized 
phospholipids have a variety of pro-inflammatory 
effects (Watson et al., 1997; Subbanagounder et al., 
2002a; Spickett & Dever, 2005), and lipid chlorohy-
drins have previously been found to cause cell lysis, 
toxicity, and loss of muscle tension (Carr et al., 1997; 
Iwase et al., 1997; Vissers et al., 2001), we hypoth-
esized that phospholipids and fatty acid chlorohy-
drins could contribute to deleterious and pro-inflam-
matory effects of HOCl-modified LDL. In a previous 
study we had found that phospholipid chlorohy-
drins caused toxicity to HL60 cells similar to that 
observed following treatment with autooxidized 
palmitoyl-arachidonoyl phosphatidylcholine and the 
lipid peroxidation product 4-hydroxynonenal (De-
ver et al., 2003). Here we have extended the study 
to look at the effects of fatty acid chlorohydrins and 
phospholipid chlorohydrins on U937 cell ATP lev-
els and caspase-3 activation, and have investigated 
whether phospholipid chlorohydrins can induce en-
dothelial-leukocyte adhesion, which is an early event 
in atherosclerotic plaque formation.
MATerIALs AnD MeTHODs
C57Bl/6 (Harlan, UK Ltd) mice were bred in-
house at the University of Strathclyde under a project 
licence authorised under the UK Animals (Scientific 
Procedures) Act. All phospholipids and fatty acids 
were purchased from Sigma-Aldrich Chemical Com-
pany (Poole, UK), and were prepared individually 
in chloroform at a concentration of 10 mg/mL. The 
myeloid cell line U937 was obtained from the Euro-
pean Collection of Animal Cell Cultures (UK).
Preparation of chlorohydrins. Aliquots of 
each lipid were dried under nitrogen and reconsti-
tuted by whirlimixing in an equal volume of Hanks 
buffered saline solution (HBSS), followed by sonica-
tion at 35oC for 15 min, to form lipid vesicles. The 
vesicles were treated with a 10-fold molar excess of 
sodium hypochlorite at pH 6.0 until optimal conver-
sion of the native lipid was achieved (between 15 
and 50 min, depending on the lipid used). Excess 
hypochlorite was removed by passing the incuba-
tion mixture through reverse phase Sep-pak car-
tridges (Waters, UK) for phospholipids or normal 
phase cartridges for fatty acids. The columns were 
washed with water followed by methanol, and lip-
ids were eluted with 1 : 1 methanol/chloroform fol-
lowed by 100% chloroform. The organic solvent was 
removed under a stream of nitrogen and the lipid 
chlorohydrins were reconstituted in HBSS and fil-
tered through a 0.2 micron gamma-sterilised filter 
prior to addition to the cells.
Analysis of chlorohydrins. The conversion 
of native lipids to chlorohydrins was monitored by 
electrospray mass spectrometry (ES-MS). One mi-
crolitre aliquots were removed and diluted 200-fold 
with 71:5:7 (by vol.) methanol/hexane/0.1 M ammo-
nium acetate. ES-MS was carried out on Platform 
(VG) or LCQ-Duo (Finnigan) mass spectrometers in 
positive ion mode by direct infusion. A spectrum in 
the range 650–1050 m/z was obtained for phospholi-
pids and 200–600 m/z for fatty acids, and both loss of 
the native lipids and appearance of chlorohydrins at 
multiples of +52/+54 m/z was monitored as described 
previously (Jerlich et al., 2000).
Analysis of cellular ATP levels for viabil-
ity. U937 cells were cultured at 37oC in RPMI-1640 
medium containing 2 mM l-glutamine and 25 mM 
Hepes, and supplemented with 10% foetal calf se-
rum, 80 U/mL penicillin, and 0.08 mg/mL strepto-
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mycin. Treatments were carried out in 96-well lu-
minescence plates (Greiner, UK) containing 1 × 104 
cells per well (100 µL volume). Aliquots (100 µL) of 
the sterile chlorohydrin preparations were added to 
wells, and the plate was incubated at 37oC in a hu-
midified atmosphere with 95% O2 and 5% CO2 for 
24 h. At the end of this period, the cellular ATP lev-
els were determined by the CellTitre-GloTM Lumi-
nescence assay (Promega), as described previously 
(Dever et al., 2003). The results are expressed as a 
percentage of control viability, to allow comparison 
between individual experiments.
Caspase-3 assays. Caspase-3 activity was 
measured by a colorimetric assay based on the hy-
drolysis of acetyl-Asp-Glu-Val-Asp p-nitroaniline 
(Ac-DEVD-pNA) to release p-nitroaniline (pNA). 
U937 cells (2 × 106 cells in 2.5 mL) were treated 
with phospholipid chlorohydrins. Following treat-
ment, cells were washed with phosphate buffered 
saline (PBS) and then disrupted in 100 µL of lysis 
buffer (50 mM Hepes, pH 7.5, 0.1% Chaps, 1 mM 
dithiothreitol, 0.1 mM EDTA, 0.1% Triton X-100, 0.5 
mM PMSF, 1 µg/mL aprotinin, 10 µM leupeptin, 1 
µM pepstatin) by 15 min incubation on ice, 15 min 
sonication, and freeze-thawing. The cellular extract 
was clarified by centrifugation at 10 000 × g at 4oC 
and 25 µL were used per assay in 96-well plates. 
Ac-DEVD-pNA was prepared in assay buffer (50 
mM Hepes, pH 7.5, 100 mM NaCl, 10 mM DTT, 1 
mM EDTA, 10% glycerol, 0.5 mM PMSF, 1 µg/mL 
aprotinin, 10 µM leupeptin, 1 µM pepstatin) and 
used at a final concentration of 200 µM in a total 
assay volume of 200 µL/well. Selected wells con-
taining cell extract were also pre-treated with the 
specific caspase-3 inhibitor Ac-DEVD-CHO for 30 
min at 10 µM.
Leukocyte isolation and radiolabelling. 
C57Bl/6 (18–24 g) mice were euthanized by CO2 as-
phyxiation. Spleens were removed and disrupted 
over a 200 µm mesh (Cadisch Ltd) into 3 mL of 
RPMI-1640 medium (Dutch Modification: Invitrogen 
Ltd, UK) containing 10% foetal calf serum (Invit-
rogen). The resulting cell suspensions were passed 
through a 200 µm mesh and centrifuged at 125 g 
for 10 min. The supernatants were removed, and the 
pellets containing the cells were agitated with 4 mL 
of distilled water for 30 s to lyse erythrocytes; 4 mL 
of 1.8% NaCl were then added, to maintain an iso-
tonic solution, and the leukocyte suspensions were 
passed through a 200 µm mesh and centrifuged. The 
resulting cell pellets were re-suspended to a final 
density of 1 × 106 cells per mL. One millilitre of the 
re-suspended leukocytes was labelled for 1 h at 37°C 
in a humidified chamber with 5 µL (185 kBq) of 51Cr 
(as Na2CrO4; Amersham Biosciences, UK). The cells 
were washed twice with RPMI and re-suspended in 
RPMI to 1 × 106 cells per mL.
Artery segment preparation and leukocyte 
adhesion. Homologous aortic trees from the eutha-
nized C57Bl/6 mice were removed and cut into three 
segments (aortic arch, thoracic aorta and abdominal 
aorta). Each segment was pinned out luminal-side 
up onto a Sylgard block (Dow Corning, Germany) 
before placing in a humidified chamber at 37°C, and 
incubating with RPMI-medium or 25 µM SOPC chlo-
rohydrin for 1, 2 or 4 h. The segments were washed 
with RPMI before addition of 5 µL aliquots of 51Cr-
labelled cells to the artery segments and incubation 
for 30 min. The segments were then washed again 
with RPMI, transferred into microtubes and assayed 
for 51Cr on a gamma counter (Cobra™ Auto-gam-
ma®, Packard, Canberra Company, UK). Microtubes 
containing 5 µL aliquots of labelled and unlabelled 
cells were also included in the counting process, to 
allow calculation of leukocyte adhesion as a percent-
age of the total radioactivity added to the tissue seg-
ments. 
Following the adhesion assay, tissue samples 
were fixed in 4% formaldehyde in saline, washed in 
PBS before dehydration through graded alcohols and 
HistoClear (Fisher, UK), and embedded in paraffin 
wax. Sections (4 microns) were cut and mounted on 
glass slides for haematoxylin and eosin staining.
statistical analysis. Multiple group com-
parisons for percentage splenocyte adhesion were 
performed using One-way ANOVA and Tukey’s 
Post-Hoc test. For analysis of data from caspase-3 
assays and ATP levels, a Student’s t-test was used 
to compare native versus chlorohydrin treatments, 
and One-way ANOVA was used for comparison of 
treatment concentrations versus control (0 µM lipid 
or chlorohydrin).
resULTs
The formation of chlorohydrins of the phos-
pholipids and fatty acids was monitored using direct 
infusion electrospray mass spectrometry in positive 
ion mode. The spectra of the chlorohydrin prepara-
tions of stearoyl-oleoyl phosphatidylcholine (SOPC), 
stearoyl-linoleoyl phosphatidylcholine (SLPC) and 
stearoyl-arachidonoyl phosphatidylcholine (SAPC) 
were essentially as reported previously (Dever et al., 
2003), and showed nearly complete conversion of 
the native lipid to the chlorohydrin for SOPC and 
SLPC, and approx. 50% conversion for SAPC (not 
shown). Likewise with the fatty acid chlorohydrins, 
it was found that oleic acid had undergone almost 
complete conversion to the chlorohydrin form. Lino-
leic acid had undergone approx. 80% conversion to 
chlorohydrins with the mono-chlorohydrin predomi-
nating but some bis-chlorohydrin also present. With 
arachidonic acid, as with SAPC, a less complete 
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conversion of approx. 60% to multiple chlorohydrin 
forms was achieved. More extensive conversion was 
not attempted, in order to avoid the formation of 
lysolipids, which has been reported previously for 
the arachidonate moiety (Panasenko et al., 2003). The 
mono-chlorohydrin of arachidonic acid was the ma-
jor product, but bis-, tris-, and tetra-chlorohydrins 
with various mixtures of 35Cl and 37Cl isotope ratios 
were also found (not shown). 
Cultured myeloid cells were incubated with 
both native lipids and the chlorohydrin preparations 
for 24 h, and the cellular ATP levels were then deter-
mined (Fig. 1). Panels A, C, and E show the effect of 
the phospholipid chlorohydrins on U937 cells, while 
Figure 1. effect of fatty acid and phospholipid chlorohydrins on ATP levels.
U937 cells were incubated for 24 h in RPMI-1640 medium containing chlorohydrins at the concentrations indicated in 
the graphs. Following treatment, the cellular ATP level was determined using luciferin-luciferase in a bioluminescent as-
say, and the percentage ATP level of the cells was calculated by comparison with untreated cells. In each panel the dark 
bars show treatment with native lipid, and light bars show treatment with the corresponding chlorohydrin. A) Stearoyl-
oleoyl phosphatidylcholine; B) oleic acid; C) stearoyl-linoleoyl phosphatidylcholine; D) linoleic acid; E) stearoyl-arachido-
noyl phosphatidylcholine; F) arachidonic acid. The data are the average of 3 separate experiments each carried out in 
triplicate, and the error bars correspond to 1 standard deviation. Significant differences compared to control (0 mM) are 
shown by * and differences compared to native lipid are shown by #, where 1 symbol corresponds to P < 0.05, 2 symbols 
corresponds to P < 0.01, and 3 symbols corresponds to P < 0.001.
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panels B, D, and F show the effect of the fatty acid 
chlorohydrins on these cells. It can be seen that all 
of the lipid chlorohydrin treatments caused deple-
tion of cellular ATP compared to control cells incu-
bated with RPMI medium only, and also compared 
to cells treated with an equivalent concentration of 
unmodified lipid. It appeared that the free fatty acid 
chlorohydrins caused slightly greater depletion of 
ATP than the corresponding phospholipid chlorohy-
drins: this was significant for oleic acid versus SOPC 
at 25 µM (P = 0.004) and 50 µM (P = 0.01), but there 
were no significant differences for linoleic acid ver-
sus SLPC or arachidonic acid versus SAPC, though 
the latter just failed to reach significance at 25 µM 
(P = 0.09). Both the free form and esterified forms 
of oleic acid appeared to cause the greatest ATP de-
pletion, followed by the free and esterified forms of 
arachidonic acid, with linoleic acid in either form 
having the least effect on the cellular ATP. However, 
it should be noted that the conversion of SAPC and 
arachidonic acid to chlorohydrins was not as com-
plete as the other two lipids, and consequently the 
real effects of SAPC chlorohydrin and arachidonic 
acid chlorohydrin are slightly greater than is appar-
ent from the graph. It was noted that treatment with 
unmodified SAPC also caused a significant loss of 
ATP, in agreement with previous observations (De-
ver et al., 2003); this effect was less pronounced with 
free arachidonic acid.
To investigate whether apoptosis might con-
tribute to the toxicity observed with the chlorohy-
drins, caspase-3 activation was monitored in U937 
cells incubated with SOPC chlorohydrin or SAPC 
chlorohydrin for 24 h (Fig. 2). It was found with 
both lipids that incubation with 25 µM chlorohydrin, 
the lowest concentration tested in this assay, caused 
a significant increase in caspase-3 activity (approx. 
100–150% increase). Increasing the chlorohydrin con-
centration further resulted in a decrease in caspase-3 
activity compared to 25 µM. Inclusion of the specific 
caspase-3 inhibitor Ac-DEVD-CHO in the assay re-
sulted in a substantial abrogation of caspase-3 acti-
vation.
SOPC chlorohydrin was then selected for fur-
ther studies of more physiological effects of chloro-
hydrin using an ex-vivo model of leukocyte-arterial 
adhesion as described previously (Lim et al., 2006; 
Dever et al., 2006). Adhesion of splenocytes to the 
endothelial surface could be visualized by micro-
graphs (Fig. 3A) and was quantitated by 51Cr-la-
belled splenocyte-dependent radioactivity of the 
arterial segments. It was found that incubation of 
mouse artery segments with SOPC chlorohydrin 
caused significant enhancement of splenocyte adhe-
sion to the endothelium (Fig. 3B). Incubation of ar-
tery segments with 25 µM SOPC chlorohydrin for 10 
min was not long enough to stimulate increased ad-
hesion of radiolabelled splenocytes, but longer incu-
bation times (1–4 h) caused approximately a 3-fold 
increase in adhesion of splenocytes to aortic, thorac-
ic and abdominal artery segments. The increase in 
all segments was maximal or nearly maximal at 1 h; 
extending the incubation period to 2 or 4 h did not 
greatly enhance the splenocyte adhesion. Incubation 
with unmodified SOPC did not cause any increase 
in adhesion (not shown).
DIsCUssIOn
It is becoming increasingly accepted that 
HOCl-modified LDL is important in atherosclerosis, 
but the contributions of lipid modifications versus 
protein modifications are not completely understood. 
As HOCl treatment of LDL generates chlorohydrins, 
these could contribute to adverse effects of HOCl-
LDL at a cellular and tissue level. The first finding 
Figure 2. effect of phospholipid chlorohydrins on cas-
pase-3 activity.
U937 cells were incubated for 24 h in medium containing 
the chlorohydrins. The caspase-3 activity was assayed in 
cell extracts by measuring absorbance at 405 nm corre-
sponding to the release of p-nitroaniline from acetyl-Asp-
Glu-Val-Asp p-nitroaniline (Ac-DEVD-pNA). Pre-treatment 
with the specific caspase-3 inhibitor Ac-DEVD-CHO was 
for 30 min at 10 µM. Controls correspond to cells treated 
with medium only. A) Stearoyl-oleoyl phosphatidylcholine 
chlorohydrin (n = 4), and B) stearoyl-arachidonoyl phos-
phatidylcholine chlorohydrin (n = 2). Error bars corre-
spond to 1 standard deviation. Significant differences are 
relative to control (0 mM), where * corresponds to P < 0.05, 
** to P < 0.01, and *** to P < 0.001.
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of this study was that both phospholipid and fatty 
acid chlorohydrins caused similar depletion of cel-
lular ATP levels in cultured myeloid U937 cells. 
The loss of cellular ATP indicates that the cells are 
stressed and that loss of viability is occurring, which 
is in agreement with previous studies that have 
shown toxic effects of fatty acid or cholesterol halo-
hydrins on erythrocytes and endothelial cells (Carr 
et al., 1997; Vissers et al., 2001). However, meas-
urement of cellular ATP levels cannot distinguish 
between apoptosis and necrosis, so the effect of 
SOPC- and SAPC-chlorohydrins on cellular caspase-
3 activity was also assayed to investigate whether a 
lipid chlorohydrin might be able to induce apopto-
sis. Caspase-3 activation was evident at lower treat-
ment severity than loss of ATP and diminished as 
the treatment concentration increased, consistent 
with the idea that the mode of cell death is dose-
dependent, with lower doses causing apoptosis and 
higher doses diminishing apoptosis but increasing 
necrosis (Buttke & Sandstrom, 1994; Vayssier et al., 
1998; Vissers et al., 1999). Similar concentrations (10 
µM) of palmitoyl-arachidonoyl phosphatidylcholine 
oxidation products have previously been found to 
induce apoptosis and caspase-3 activation in arterial 
smooth muscle cells (Loidl et al., 2003), via activation 
of acid sphingomyelinase. Possibly the chlorinated 
oxidation products of phospholipids could act by a 
similar mechanism.
Our results suggest that lipid chlorohydrins 
may have more complex cellular effects than previ-
ously thought. Earlier studies have mainly focused 
on membrane disruption as a mechanism for toxic-
ity; as chlorohydrins are more polar than native lip-
ids, their formation within membrane or subsequent 
incorporation was thought to disrupt the lipid bi-
layer structure, and result in toxicity simply through 
physical effects (Carr et al., 1997). In studies on hu-
man endothelial cells, the mechanism of cell death 
was described as necrotic rather than apoptotic, and 
similar to that observed with higher doses of di-
rect HOCl treatment (Vissers et al., 2001), although 
lower doses of HOCl induced apoptosis (Vissers et 
al., 1999). However, this may relate to the lipid chlo-
rohydrin concentration used by Vissers et al. (2001) 
when observing morphological changes, of which 
the lowest tested was 37.5 µM.
The other major finding of the study was that 
treatment of arterial segments with SOPC chloro-
hydrin induced a significant increase in splenocyte 
adhesion within one hour. The treatment of arterial 
segments was carried out at a low chlorohydrin con-
centration (25 µM) and over relatively short time pe-
riods, as previously we have found that toxic effects 
of phospholipid chlorohydrins only became appar-
ent after 6 h (Dever et al., 2003). This was important 
to ensure that the increased adhesion observed fol-
lowing chlorohydrin treatment was not simply due 
to cell death and release of cell components that 
could be pro-inflammatory. Thus it appears that 
phospholipid chlorohydrin can cause a pro-inflam-
matory effect comparable to that observed with au-
tooxidized palmitoyl-arachidonoyl phosphatidylcho-
line (PAPC) (Watson et al., 1997). Furthermore, the 
concentration that induces this effect is similar to the 
concentrations of PAPC oxidation products, such as 
palmitoyl-oxovaleroyl phosphatidylcholine and hy-
droxy alkenal derivatives of phosphatidylcholines, 
which have also been found to cause adhesion of 
monocytes to human aortic endothelial monolayers, 
and increased production of MCP-1 and IL-8 (Sub-
banagounder et al., 2002b). This further supports the 
Figure 3. effect of sOPC chlorohydrin on splenocyte-ar-
terial adhesion.
C57Bl/6 artery segments were incubated with 25 µM 
stearoyl-oleoyl phosphatidylcholine chlorohydrin before 
addition of 51Cr-labelled splenocytes for 30 min. A) Micro-
graph of an artery segment stained with haematoxylin and 
eosin showing adherent splenocytes (SP), endothelium (E), 
and smooth muscle cells (SMC). B) The adhesion of splen-
ocytes was quantitated by measurement of segment radi-
oactivity and the results are shown as percentage of the 
total radioactivity added per segment. The segments were 
incubated with chlorohydrin for 0 min (control, n = 11), 
10 min (n = 5), 1 h (n = 10), 2 h (n = 8) or 4 h (n = 10). 
Error bars are 1 standard error of the mean and * indicates 
P < 0.05 compared to control.
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hypothesis that chlorohydrins, in addition to causing 
necrosis at high concentrations, may act on cells in 
more subtle ways to alter cell functions. The mecha-
nism of chlorohydrin-induced adhesion to arterial 
segments is currently unknown, and further study is 
warranted to investigate this.
This study has presented the first evidence 
that phospholipid chlorohydrins can induce inflam-
matory cell-endothelial adhesion, and therefore that 
HOCl-modification of the phospholipid moiety of 
LDL may contribute to the pro-inflammatory and 
pro-atherogenic effects of HOCl-LDL that have been 
reported previously.
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